WebJul 23, 2024 · Harvey A. Risch, MD, PhD , Professor of Epidemiology, ... These seven studies include: an additional 400 high-risk patients treated by Dr. Vladimir Zelenko, with zero deaths; four studies totaling ... WebOct 17, 2024 · Dr. Harvey Risch: No. I put it the other way around. The unvaccinated should be afraid of the vaccinated. They’re just as infected. In fact, maybe more infected. If vaccinated, people are infected. So it is well known that it is the vaccinated people that generate the mutant strains and not the unvaccinated people. And that has led that ...
The Key to Defeating COVID-19 Already Exists. We Need to
WebApr 22, 2024 · The article pictured goes on to quote Yale professor Dr. Harvey Risch: "Clinicians have been telling me that more than half of the new COVID cases that they’re … WebDec 11, 2024 · December 10, 2024 Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health, attends the inaugural conference of the Brownstone Institute in Hartford, Connecticut, on Nov. 14, 2024 The COVID-19 pandemic has been one of fear, manufactured by individuals who were in the nominal positions of authority as the virus … the trade way forgotten realms
American Thought Leaders: Dr. Harvey Risch: Why Are
WebDec 3, 2024 · Dr. Harvey Risch presented his analysis of the research involving early treatment, focusing on the outpatient use of hydroxychloroquine because it is the most studied drug. Dr. Risch emphasized outpatient treatment of symptomatic high-risk patients within the first 5 to 7 days of illness with the “HCQ cocktail, ” consisting of HCQ in ... WebOct 4, 2024 · Harvey Risch is a brilliant contributor to the knowledge base of biomedical research. Dr. Risch was the first to publish on hydroxychloroquine, very early in the pandemic, summarizing in the American Journal of Epidemiology evidence that hydroxychloroquine (HCQ) was associated with lowered mortality risk in a dose … WebAug 29, 2024 · In May 2024, the Journal published an opinion piece by a member of the Editorial Board, Dr. Harvey Risch , in which he reviewed several papers—published and unpublished—and argued that using hydroxychloroquine (HCQ) + azithromycin (AZ) early to treat symptomatic coronavirus disease 2024 (COVID-19) cases in high-risk patients early … severance brewing company